Status:
UNKNOWN
Human Chorionic Gonadotrophin & Trigger
Lead Sponsor:
Cairo University
Conditions:
Ovulation Disorder
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
In women being treated with medicines to help eggs to grow (called ovulation induction), The investigators wish to know whether adding medicines (called ovulation triggers) that help to release the eg...
Detailed Description
Women will be treated with clomiphene citrate to help eggs to develop to additionally receive a medicine (urinary hCG) to trigger their release or to receive no additional treatment. the investigators...
Eligibility Criteria
Inclusion
- Normoprolactinemic and normogonadotropic (WHO class II ovarian dysfunction )
- Primary infertility with oligomenorrhea (bleeding intervals between 35 days and 6 months) or amenorrhea (bleeding interval more than 6 months)
- Age 18-40 years
- Duration of primary infertility more than2 years
- No history of ovulation induction treatment
- No history of thyroid disease
- Normal results on hysterosalpingogram
- Husband with normal semen analysis
- \-
Exclusion
- Ovarian cyst
- Endometrioma
- Liver disease
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02264847
Start Date
October 1 2014
End Date
May 1 2017
Last Update
February 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine , Cairo University
Cairo, Cairo Governorate, Egypt, 12311